| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,181 |
14,845 |
$893K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,017 |
13,945 |
$570K |
| 87428 |
|
9,297 |
7,818 |
$422K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,826 |
4,717 |
$358K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,664 |
4,276 |
$324K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
16,046 |
6,330 |
$166K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,048 |
2,011 |
$162K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,057 |
8,417 |
$127K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,581 |
1,477 |
$124K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,932 |
2,684 |
$84K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,512 |
1,259 |
$56K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,448 |
4,396 |
$51K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
565 |
560 |
$50K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,913 |
1,676 |
$49K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
988 |
911 |
$48K |
| 87634 |
|
834 |
769 |
$48K |
| 92558 |
|
6,878 |
6,740 |
$47K |
| 99429 |
|
2,032 |
1,990 |
$44K |
| 87807 |
|
3,374 |
2,732 |
$34K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
89 |
25 |
$28K |
| 90461 |
|
4,790 |
4,059 |
$26K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
220 |
211 |
$18K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,105 |
1,055 |
$12K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
25 |
24 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
493 |
387 |
$5K |
| 99383 |
|
54 |
54 |
$4K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
458 |
389 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
191 |
153 |
$2K |
| 99382 |
|
26 |
26 |
$2K |
| 96160 |
|
1,194 |
1,179 |
$1K |
| 99215 |
Prolong outpt/office vis |
15 |
12 |
$957.16 |
| 81002 |
|
202 |
182 |
$563.56 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
17 |
15 |
$413.80 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$251.39 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
160 |
143 |
$227.02 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
54 |
45 |
$50.84 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
143 |
124 |
$18.85 |
| 90671 |
|
1,018 |
998 |
$0.48 |
| 90744 |
|
1,492 |
1,452 |
$0.00 |
| 90698 |
|
3,136 |
3,021 |
$0.00 |
| 90680 |
|
2,193 |
2,104 |
$0.00 |
| 90686 |
|
2,245 |
2,184 |
$0.00 |
| 90647 |
|
53 |
52 |
$0.00 |
| 90696 |
|
14 |
14 |
$0.00 |
| 90619 |
|
17 |
15 |
$0.00 |
| 90670 |
|
2,491 |
2,405 |
$0.00 |
| 90710 |
|
812 |
784 |
$0.00 |
| 90633 |
|
1,175 |
1,149 |
$0.00 |
| 99188 |
|
250 |
247 |
$0.00 |
| 90700 |
|
27 |
27 |
$0.00 |